Clinical trials
Phase 2/3 trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 9 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Recruiting | 21 |
| Terminated | 21 |
| Active, not recruiting | 7 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 8 |
| CSL Behring | 3 |
| Janssen Research & Development, LLC | 3 |
| Novartis | 3 |
| AstraZeneca | 2 |
| Baxalta now part of Shire | 2 |
| Bayer | 2 |
| Celgene | 2 |
| Eli Lilly and Company | 2 |
| Ferring Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Colitis, Ulcerative | 6 |
| Lung Neoplasms | 5 |
| COVID-19 | 4 |
| Diabetes Mellitus, Type 2 | 4 |
| Hemophilia A | 4 |
| Inflammatory Bowel Diseases | 3 |
| Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.